Physician-owners and administrators running independent ambulatory surgery centers (ASCs) are racing to capture high-margin surgical procedures—orthopedics, spine, GI, ophthalmology—that are rapidly migrating out of hospital systems. With CMS adding 573 new procedure codes to the ASC list in 2026 and the U.S. ASC market valued at $93.25 billion and growing, independent operators who can't win surgeons, negotiate payer contracts, and control implant costs will get squeezed out or absorbed by private equity.
CMS added 573 new procedure codes to the ASC-approved list in 2026—one of the largest single-year expansions ever—unlocking complex spine and cardiac cases that were previously hospital-only and giving independent ASCs a direct shot at high-revenue volume they couldn't touch before (CertifyHealth, May 2026).
The U.S. ASC market hit $93.25 billion in 2026 growing at 5.2% CAGR, driven by payers aggressively steering complex procedures to lower-cost outpatient settings—every procedure a payer redirects from a hospital to an ASC is a new revenue opportunity for the ASC that captures it (Research and Markets, August 2026).
61% of ASCs named recruiting new surgeons their biggest physician-related risk for 2026 according to a VMG Health survey, and hospital systems are using 'no-leakage' employment contracts to lock surgeons in—making surgeon acquisition the single biggest competitive lever for independent operators right now (Becker's ASC, June 2026).
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.
Also in Health. Sorted by how fast they are growing.
Med spa owner-operators — NPs, PAs, and physicians running revenue-generating aesthetic practices — are facing a wave of new state laws, active enforcement sweeps, and license revocation risk. With 2026 marking the first year of direct legislative regulation in multiple states, owners need operational compliance infrastructure now: the right agreements, SOPs, and physician oversight structures to protect their license and revenue stream.
Affluent adults aged 35–60 who already biohack their health are self-administering injectable peptides to lose fat, recover faster, slow aging, and boost performance. They pay $200–$1,000 per month out of pocket with no insurance coverage, yet have almost no trusted tools to verify product purity, guide protocol decisions, or track results.
People with health insurance who just got a denial letter and want to fight it but feel buried in paperwork and jargon. AI tools now generate the full appeal letter in under 60 seconds, removing the only real barrier that stopped most people from winning money that was already owed to them.
College-educated women ages 25–55 who spent years getting dismissed by conventional doctors are now self-directing their own SIBO and gut recovery protocols through stacked supplements, at-home breath tests, and functional medicine telehealth. Their core goal is getting their daily life back after years of debilitating bloating, pain, and misdiagnosis — not wellness optimization.